Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0360-3016(02)02913-9PMID 12182977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carcinoma of the corpus uteri

  2003cited by this paper
• Carcinoma of the corpus uteri.

  2001cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.

  2001cited by this paper
• Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.

  2000cited by this paper
• The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

  2000cited by this paper
• The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease.

  1998cited by this paper
• The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm.

  1997cited by this paper
• Clear cell carcinoma of the endometrium: Prognosis and metastatic pattern

  1996cited by this paper
• Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

  1995cited by this paper
• Uterine papillary serous carcinoma: patterns of metastatic spread.

  1994cited by this paper
• Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

  1991cited by this paper
• Endometrial adenocarcinoma in Norway. A study of a total population

  1991cited by this paper
• Relationship between surgical‐pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study

  1991cited by this paper
• Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium.

  1990cited by this paper
• Chylous ascites after whole-abdomen irradiation for gynecologic malignancy.

  1990cited by this paper
• Uterine papillary serous carcinoma

  1987cited by this paper
• Clear cell carcinoma of the endometrium

  1987cited by this paper
• Two pathogenetic types of endometrial carcinoma.

  1983cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Insights from the Pre-Molecular Era in Advanced Endometrial Cancer: Benchmarking Prognostic Indicators in High-Risk Tumours

  2025cites this paper
• Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.

  2023cites this paper
• Importance of p53, bcl-2 genes in uterine body cancer and their role in prediction

  2022cites this paper
• Association between subtypes of metabolic syndrome and prognosis in patients with stage I endometrioid adenocarcinoma: A retrospective cohort study

  2022cites this paper
• Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer – a population-based study

  2021cites this paper
• Clinicopathological characteristics and prognosis of uterine serous carcinoma: A SEER program analysis of 1016 cases

  2021cites this paper
• High‐risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels

  2021cites this paper
• Unique prognostic features of grade 3 endometrioid endometrial carcinoma: Findings from 101 consecutive cases at a Japanese tertiary cancer center.

  2021cites this paper
• Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients

  2021cites this paper
• High-grade endometrial cancer survival (endometrioid to non-endometrioid histology comparison)

  2020cites this paper
• Role of Immunohistochemistry to Distinguish Grade 3 Endometrioid Carcinoma and Uterine Serous Carcinoma

  2020cites this paper
• Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience.

  2019cites this paper
• Clear cell gynecologic carcinomas: about 5 cases

  2019cites this paper
• A novel model to predict cancer‐specific survival in patients with early‐stage uterine papillary serous carcinoma (UPSC)

  2019cites this paper
• Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.

  2019cites this paper
• Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study

  2019cites this paper
• High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations

  2018cites this paper
• Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas

  2018cites this paper
• Uterine sarcomas

  2018cites this paper
• Uterine Cancer

  2018influential citation
• Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine Carcinosarcoma

  2017cites this paper
• Disparities in the surgical staging of high-grade endometrial cancer in the United States

  2017cites this paper
• Endometrial Cancer: Advanced Stage

  2017cites this paper
• Cyclin B1 mediates the effect of UCHL1 in promoting cell cycle progression in uterine papillary serous carcinoma

  2017cites this paper
• Nonendometrioid Endometrial Carcinomas and Uterine Sarcomas

  2017cites this paper
• Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion.

  2017cites this paper
• Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.

  2016cites this paper
• Improved Outcome of High-Grade, Early 1-Stage Endometrioid Endometrial Carcinoma With Adjuvant Chemotherapy and Radiotherapy: Comparison of 2 Treatment Strategies

  2016cites this paper
• MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis

  2016cites this paper
• Survival Differences Among Uterine Papillary Serous, Clear Cell and Grade 3 Endometrioid Adenocarcinoma Endometrial Cancers: A National Cancer Database Analysis

  2016cites this paper
• Uterine sarcomas

  2015cites this paper
• Significance of Lymphovascular Space Invasion in Uterine Serous Carcinoma: What Matters More; Extent or Presence?

  2015cites this paper
• The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry

  2015cites this paper
• Adjuvant radiation therapy is associated with improved pelvic control and overall survival in FIGO IB endometrial carcinoma with high grade histology.

  2015cites this paper
• Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer

  2015cites this paper
• Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.

  2015cites this paper
• Prognostic Factors in Uterine Cancer

  2015cites this paper
• Clear cell endometrial cancer: a CTF multicentre Italian study.

  2015cites this paper
• Correlation of progression-free and post-progression survival with overall survival in phase III trials of first-line chemotherapy for advanced epithelial ovarian cancer.

  2015cites this paper
• Immunohistochemical characterization of endometrial carcinomas: Endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis

  2014cites this paper
• Improving oncologic outcomes for women with endometrial cancer: realigning our sights.

  2014cites this paper
• An investigation into tetraspanin CD151 as novel prognostic markers in poor outcome endometrial cancer

  2014cites this paper
• The Occurrence of Fetal Microchimeric Cells in Endometrial Tissues Is a Very Common Phenomenon in Benign Uterine Disorders, and the Lower Prevalence of Fetal Microchimerism Is Associated with Better Uterine Cancer Prognoses

  2014cites this paper
• Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.

  2014cites this paper
• Adjuvant Chemotherapy With External BeamRadiation Therapy for High-Grade, Node-Positive Endometrial Cancer

  2014cites this paper
• Management of uterine sarcoma

  2014cites this paper
• Uterine Clear Cell Carcinoma

  2014cites this paper
• The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.

  2013cites this paper
• Quantifying the risk of recurrence and death in stage III (FIGO 2009) endometrial cancer.

  2013cites this paper
• A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system

  2013influential citation
• Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients

  2013cites this paper
• Redefining Stage I Endometrial Cancer: Incorporating Histology, a Binary Grading System, Myometrial Invasion, and Lymph Node Assessment

  2013cites this paper
• Adjuvant Radiation Therapy for Patients With Type II Endometrial Carcinoma: Impact on Tumor Recurrence and Survival

  2013cites this paper
• Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.

  2013cites this paper
• Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.

  2013cites this paper
• High‐grade endometrial carcinomas – strategies for typing

  2013cites this paper
• Molecular Profile of Grade 3 Endometrioid Endometrial Carcinoma: Is it a Type I or Type II Endometrial Carcinoma?

  2012influential citation
• Uterine Endometrial Carcinoma: 10 Years’ Experience with Long-Term Follow-Up at a Single Korean Institution

  2012cites this paper
• Nonendometrioid Endometrial Carcinomas and Uterine Sarcomas

  2012cites this paper
• Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression

  2012cites this paper
• Targeted therapy for high-risk endometrial carcinoma

  2012cites this paper
• Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma.

  2012cites this paper
• Uterine Pathology: Index

  2012cites this paper
• Prognosis of high-grade endometrial cancer: a comparison of serous-type and clear cell type to grade 3 endometrioid-type.

  2012cites this paper
• Tumor-stromal interactions in Type I and Type II endometrial cancer: The role of CXCL12/CXCR4 and HGF/c-Met/bFGF in a large cohort of endometrial cancer patients

  2011cites this paper
• Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): What is destined for the atypical endometrial hyperplasia?

  2011cites this paper
• [Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].

  2011cites this paper
• Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma

  2011cites this paper
• Which is worse: uterine papillary serous carcinomas or carcinosarcomas?

  2011cites this paper
• Uterine Papillary Serous, Clear Cell, and Poorly Differentiated Endometrioid Carcinomas: A Comparative Study

  2011cites this paper
• Malignant mixed müllerian tumor with a lung metastasis: Fine needle aspiration cytology and histology correlation

  2011cites this paper
• Prognostic Significance of Lymphovascular Space Invasion and Nodal Involvement in Intermediate- and High-Risk Endometrial Cancer Patients Treated With Curative Intent Using Surgery and Adjuvant Radiotherapy

  2011cites this paper
• Clear Cell Cancers of Uterus

  2011cites this paper
• Clear cell carcinoma of the endometrium: a biological and clinical enigma.

  2010cites this paper
• A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy.

  2010cites this paper
• Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.

  2010cites this paper
• Ergebnisse der adjuvanten Strahlentherapie beim Endometriumkarzinom im Stadium Ic an der radioonkologischen Universitätsklinik Tübingen - Eine Retrospektive Studie

  2010cites this paper
• Uterine papillary serous carcinoma: epidemiology, pathogenesis and management

  2010cites this paper
• Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium.

  2010cites this paper
• Pathologic and molecular features of uterine carcinosarcomas.

  2010cites this paper
• Uterine sarcomas: a review.

  2010cites this paper
• Long-term survival of endometrioid endometrial cancer patients

  2010influential citation
• Mixed Müllerian Tumors of the Female Genital Tract.

  2009cites this paper
• P1059 Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma

  2009cites this paper
• Review Article Insights into Endometrial Serous Carcinogenesis and Progression

  2009cites this paper
• Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review.

  2009cites this paper
• Updates on uterine papillary serous carcinoma

  2009cites this paper
• Insights into endometrial serous carcinogenesis and progression.

  2009cites this paper
• Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review.

  2009cites this paper
• Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.

  2009cites this paper
• Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas.

  2008cites this paper
• Postoperative adjuvant chemotherapy in surgically staged grade 3 endometrial cancer.

  2008cites this paper
• Prostate-Specific Membrane Antigen Expression Is a Potential Prognostic Marker in Endometrial Adenocarcinoma

  2008cites this paper
• Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube.

  2008cites this paper
• Uterine mesenchymal tumors: a review of selected topics

  2008cites this paper
• Expression von Inhibin-alpha, -betaA und -betaB im Endometriumkarzinom

  2008influential citation
• [Stage I endometrial carcinoma].

  2008cites this paper
• Cancer de l'endomètre de stade I

  2008cites this paper
• Prognostic Features of Surgical Stage I Uterine Carcinosarcoma

  2007cites this paper
• Clinicopathologic Analysis of 187 High-grade Endometrial Carcinomas of Different Histologic Subtypes: Similar Outcomes Belie Distinctive Biologic Differences

  2007cites this paper